Stock Events

Stock Events

Halozyme Therapeutics (HALO) Q3 2017 Earnings

8AugConfirmed

Q4 2016

Q1 2017

Q2 2017

Q3 2017

-0.27

-0.25

-0.23

-0.21

Details

Expected EPS

-0.24

Actual EPS

-0.23

Surprise EPS

0.01

Surprise Percent

+4.17%

Description

Halozyme Therapeutics (HALO) has reported earnings of -0.23 per share for Q3 2017.

0 Comments

Share your thoughts

Get the Stock Events App

Sign up for a Stock Events account to create your own watchlists and track your portfolio or dividends.